AI-powered liver disease detection
Reveal for Liver Disease is a breakthrough clinical solution that leverages your existing EHR data to identify patients at higher apparent risk for MASH/MASLD.
Using an advanced AI model, it flags patients who are statistically more likely to have undiagnosed MASH/MASLD, enabling timely and effective intervention.
AI-powered liver disease detection
Reveal for Liver Disease is a breakthrough clinical solution that leverages your existing EHR data to identify patients at higher apparent risk for MASH/MASLD.
Using an advanced AI model, it flags patients who are statistically more likely to have undiagnosed MASH/MASLD, enabling timely and effective intervention.
A novel identification solution for provider organizations
In the United States, 25% of adults have MASH or MASLD. Alarmingly, in clinical settings, 85% of MASH and MASLD cases go undiagnosed. Reveal for Liver Disease creates new opportunity for care teams to proactively identify and treat patients.
Streamlined patient prioritization
Reveal for Liver Disease risk-stratifies patients for priority engagement and provides a simple patient work list for care teams.
Instead of finding a needle in a haystack, focus your effort on a manageable list of screenings.
A novel identification solution for provider organizations
In the United States, 25% of adults have MASH or MASLD. Alarmingly, in clinical settings, 85% of MASH and MASLD cases go undiagnosed. Reveal for Liver Disease creates new opportunity for care teams to proactively identify and treat patients.
Streamlined patient prioritization
Reveal for Liver Disease risk-stratifies patients for priority engagement and provides a simple patient work list for care teams.
Instead of finding a needle in a haystack, focus your effort on a manageable list of screenings.
Efficient care team operations
Reveal pulls relevant data from your EHR to give a comprehensive view of patient information for making timely and informed decisions.
Care teams efficiently process prioritized patients and perform outreach as part of existing clinical workflows.
Efficient care team operations
Reveal pulls relevant data from your EHR to give a comprehensive view of patient information for making timely and informed decisions.
Care teams efficiently process prioritized patients and perform outreach as part of existing clinical workflows.
Comprehensive program tracking
With outcomes data reported daily, Reveal provides comprehensive analytics and dashboards that help you better understand program impact, care team effectiveness, and more.
Prove that your investment in early detection of liver disease is driving real value for your organization.
Assessment Productivity Metrics
Program Growth Metrics
Program Effectiveness Metrics
Why Reveal for Liver Disease?
Optimize clinical resources
Efficiently utilize specialty GI and hepatology clinicians.
Boost service line growth
Generate new outpatient specialty revenue and increase service line performance.
Fill in the gaps
Proactively treat a commonly undiagnosed comorbidity and gain a more complete picture of patient circumstances.
Manage health risks early
Address health risks in their earliest stages when they are most treatable, outcome rates are at their highest, and treatment costs are lower.
Real return from targeted screening
Consider the following screening program scenarios, for a population of 100,000 adults, with and without Reveal for Liver Disease, which targets the 5% of patients flagged for higher apparent risk of MASH/MASLD.
